Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- RECOVERY Collaborative Group
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)